Seattle’s Kivo Health raises $10M to bring lung disease rehab into patients’ homes

Kivo Health announced a $10M Series A round, bringing total funding to over $16M. The company delivers at-home treatment for chronic obstructive pulmonary disease (COPD) through shipped equipment and live therapist-led video sessions covering exercise and breathing techniques, augmented by AI-assisted ongoing support. The funding will enable national expansion and technology improvements. Kivo has approximately 50 employees including clinicians. Peer-reviewed studies report improvements in patient symptoms and mental health, with the company estimating its model could reduce annual healthcare spending.

Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. GeekWire did the reporting; read the original for the full story.